FAAH/TRPV1 blocker-1

• UNSPSC Description:

  FAAH/TRPV1 blocker-1 (compound 2R) is a dual FAAH/TRPV1 blocker, with IC50 of 0.12 and 94.9 μM, respectively. FAAH/TRPV1 blocker-1 plays an important role in analgesic and anti-inflammatory research[1].

• Target Antigen:

  FAAH; TRP Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel;Metabolic Enzyme/Protease;Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/faah-trpv1-blocker-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(OC1=CC=CC=C1)NC2(C(NCCC3=CNC4=C3C=C(OC)C=C4)=O)CCCCC2

• Molecular Weight:

  435.52

• References & Citations:

  [1]Zhenrui Qiao, et al. Novel dual-target FAAH and TRPV1 ligands as potential pharmacotherapeutics for pain management. Eur J Med Chem. 2024 Feb 1:267:116208.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported